The Searle Company Limited (PSX:SEARL)

Market Cap	57.90B +12.9%
Revenue (ttm)	33.26B +15.5%
Net Income	358.56M
EPS	0.61
Shares Out	588.22M
PE Ratio	31.80
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	7,355,519
Average Volume	3,757,065
Open	95.51
Previous Close	95.08
Day's Range	95.50 - 99.30
52-Week Range	52.75 - 137.44
Beta	0.47
RSI	60.80
Earnings Date	Apr 24, 2026

About The Searle Company

The Searle Company Limited, together with its subsidiaries, manufactures and sells pharmaceutical and other consumer products in Pakistan, Sri Lanka, Myanmar, Cambodia, Vietnam, Iraq, Oman, Afghanistan, Tajikistan, Laos, Kenya, and internationally. The company offers pharmaceutical products, such as analgesics and muscle relaxants, anti-allergy and anti-tussive, anti-anemic, anti-chelating, anti-infective, anti-neoplastic, anti-thrombotic, cardiovascular, endocrinology and metabolism, gastrointestinal, gynecology, urology and sex hormones, hepa...

• Industry: Pharmaceuticals
• Sector: Healthcare
• Founded: 1965
• Employees: 3,799
• Stock Exchange: Pakistan Stock Exchange
• Ticker Symbol: SEARL

Financial Performance

In fiscal year 2025, The Searle Company's revenue was 28.60 billion, a decrease of -2.72% compared to the previous year's 29.40 billion. Losses were -1.40 billion, -41.15% less than in 2024.